CJC-1295 with DAC and Letrozole Interaction
CJC-1295 with DAC and Letrozole have a synergistic interaction with 60% confidence. Letrozole helps manage estrogen conversion from CJC-1295 with DAC. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. Both compounds affect the pituitary, so monitoring these systems is recommended.
Compound Profiles
CJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
View full profileLetrozole
Aromatase Inhibitor | Potent Estrogen Suppression
Letrozole competitively and reversibly binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), inhibiting its catalytic activity with greater potency than any other commercially available aromatase inhibitor. Aromatase catalyzes the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.
View full profileCombined Organ Load
Frequently Asked Questions
Can I take CJC-1295 with DAC with Letrozole?
Yes, CJC-1295 with DAC and Letrozole can generally be taken together. Letrozole helps manage estrogen conversion from CJC-1295 with DAC. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.
Is CJC-1295 with DAC and Letrozole safe together?
Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between CJC-1295 with DAC and Letrozole?
Letrozole helps manage estrogen conversion from CJC-1295 with DAC. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.
How should I time CJC-1295 with DAC and Letrozole?
CJC-1295 with DAC has a half-life of 6-8 days and Letrozole has a half-life of ~2 days (48 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.